| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Oncology Unit of the Department of Medicine and the Huntington Memorial Laboratories, Massachusetts General Hospital, Boston, Massachusetts 02114
The surface membrane of the B-lymphocyte of chronic lymphocytic leukemia (CLL) has been subject to detailed investigation over the past decade. Surface immunoglobulin of low density, punctate in distribution, without the tendency to polar cap formation, and clonal with respect to light and heavy chains, is characteristic. Other B-cell properties include the presence of the la antigen and the receptor for the C3d portion of complement. The CLL surface membrane lacks such T-cell attributes as the ability to form rosettes with sheep erythrocytes and reactivity with anti-T-cell antisera, although T-cells may be increased early in the disorder. CLL is believed to be a proliferation of a B-lymphocyte of the medullary cord of the lymph node, although the exact place of this cell in lymphocyte development remains to be clarified. Surface markers are useful in distinguishing classical B-cell CLL from other proliferations of small lymphocytes (lymphosarcoma cell leukemia of follicle-center B-cells, T-cell CLL, Sézary syndrome, and reactive lymphocytosis).
1 Presented at the Conference on Cell Markers in Acute Leukemia, March 4 and 5, 1980, Bethesda, Md.
2 To whom requests for reprints should be addressed.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |